Mycophenolate mofetil, azathioprine and tacrolimus: mechanisms in rheumatology

Jasper C A Broen, Jacob M van Laar

Research output: Contribution to journalReview articlepeer-review

Abstract

The introduction of biologic DMARDs into rheumatology has resulted in a substantial reduction of the burden of many rheumatic diseases. In the slipstream of the success achieved with these biologic DMARDs, some conventional immunosuppressive drugs have also found use in new indications. Notably, mycophenolate mofetil, azathioprine and tacrolimus have made their way from solid organ transplantation drugs to become useful assets in rheumatology practice. Mycophenolate mofetil and azathioprine inhibit the purine pathway and subsequently diminish cell proliferation. Both drugs have a pivotal role in the treatment of various rheumatic diseases, including lupus nephritis. Tacrolimus inhibits lymphocyte activation by inhibiting the calcineurin pathway. Mycophenolate mofetil and tacrolimus are, among other indications, increasingly being recognized as useful drugs in the treatment of interstitial lung disease in systemic rheumatic diseases and skin fibrosis in systemic sclerosis. A broad array of trials with mycophenolate mofetil, azathioprine and/or tacrolimus are ongoing within the field of rheumatology that might provide further novel avenues for the use of these drugs. In this Review, we discuss the historical perspective, pharmacodynamics, clinical indications and novel avenues for mycophenolate mofetil, azathioprine and tacrolimus in rheumatology.

Original languageEnglish
Pages (from-to)167-178
Number of pages12
JournalNature Reviews. Rheumatology
Volume16
Issue number3
DOIs
Publication statusPublished - Mar 2020

Keywords

  • Antirheumatic Agents/pharmacokinetics
  • Azathioprine/pharmacokinetics
  • Drug Therapy, Combination
  • Enzyme Inhibitors/pharmacokinetics
  • Humans
  • Immunosuppressive Agents/pharmacokinetics
  • Mycophenolic Acid/pharmacokinetics
  • Rheumatic Diseases/drug therapy
  • Rheumatology
  • Tacrolimus/pharmacokinetics

Fingerprint

Dive into the research topics of 'Mycophenolate mofetil, azathioprine and tacrolimus: mechanisms in rheumatology'. Together they form a unique fingerprint.

Cite this